South-Eastern Asia: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in South-Eastern Asia

After two years of decline, the Southeast Asian human and animal blood market increased by X% to $X in 2021. The market value increased at an average annual rate of +X% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. As a result, consumption attained the peak level of $X. From 2019 to 2021, the growth of the market failed to regain momentum.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in South-Eastern Asia

In value terms, human and animal blood production dropped to $X in 2021 estimated in export price. Overall, production, however, recorded a noticeable decline. The most prominent rate of growth was recorded in 2018 with an increase of X% against the previous year. Over the period under review, production hit record highs at $X in 2016; however, from 2017 to 2021, production remained at a lower figure.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in South-Eastern Asia

Human and animal blood exports reached X tons in 2021, remaining relatively unchanged against 2020. Overall, exports, however, recorded a abrupt downturn. The growth pace was the most rapid in 2020 when exports increased by X% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2012; however, from 2013 to 2021, the exports failed to regain momentum.

In value terms, human and animal blood exports declined markedly to $X in 2021. Over the period under review, exports recorded resilient growth. The growth pace was the most rapid in 2020 when exports increased by X%. As a result, the exports attained the peak of $X, and then reduced rapidly in the following year.

Exports by Country

Thailand (X tons) and Singapore (X tons) prevails in exports structure, together generating X% of total exports. It was distantly followed by Vietnam (X tons), Indonesia (X tons) and Malaysia (X tons), together making up a X% share of total exports.

From 2012 to 2021, the biggest increases were in Singapore (with a CAGR of +X%), while shipments for the other leaders experienced a decline in the exports figures.

In value terms, Singapore ($X) remains the largest human and animal blood supplier in South-Eastern Asia, comprising X% of total exports. The second position in the ranking was taken by Thailand ($X), with a X% share of total exports. It was followed by Malaysia, with a X% share.

From 2012 to 2021, the average annual growth rate of value in Singapore stood at +X%. In the other countries, the average annual rates were as follows: Thailand (-X% per year) and Malaysia (+X% per year).

Export Prices by Country

The export price in South-Eastern Asia stood at $X per ton in 2021, waning by -X% against the previous year. Over the period under review, the export price, however, showed significant growth. The most prominent rate of growth was recorded in 2020 an increase of X% against the previous year. As a result, the export price attained the peak level of $X per ton, and then declined remarkably in the following year.

Prices varied noticeably by the country of origin: the country with the highest price was Singapore ($X per ton), while Vietnam ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Singapore (+X%), while the other leaders experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in South-Eastern Asia

For the seventh consecutive year, South-Eastern Asia recorded growth in overseas purchases of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, which increased by X% to X tons in 2021. Overall, imports recorded a strong expansion. The pace of growth was the most pronounced in 2019 when imports increased by X% against the previous year. The volume of import peaked in 2021 and is expected to retain growth in the immediate term.

In value terms, human and animal blood imports rose significantly to $X in 2021. Total imports indicated a prominent expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2012 indices. The most prominent rate of growth was recorded in 2017 with an increase of X%. Over the period under review, imports hit record highs in 2021 and are likely to continue growth in the near future.

Imports by Country

In 2021, Malaysia (X tons) represented the major importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, achieving X% of total imports. Vietnam (X tons) took the second position in the ranking, followed by Thailand (X tons), Singapore (X tons) and the Philippines (X tons). All these countries together took near X% share of total imports. Indonesia (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were in Vietnam (with a CAGR of +X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Thailand ($X), Singapore ($X) and Vietnam ($X) were the countries with the highest levels of imports in 2021, together comprising X% of total imports. These countries were followed by the Philippines, Malaysia and Indonesia, which together accounted for a further X Philippines, with a CAGR of +X%, saw the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the import price in South-Eastern Asia amounted to $X per ton, surging by X% against the previous year. In general, the import price, however, saw a abrupt descent. The growth pace was the most rapid in 2015 when the import price increased by X% against the previous year. The level of import peaked at $X per ton in 2017; however, from 2018 to 2021, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was Singapore ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Singapore (-X%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :